-
公开(公告)号:US20200179608A1
公开(公告)日:2020-06-11
申请号:US16794689
申请日:2020-02-19
Applicant: Insulet Corporation
Inventor: Maureen MCCAFFREY , David NAZZARO , Ian MCLAUGHLIN , Simon KOZIN
Abstract: Drug delivery systems with reduced hold-up volumes are provided. The drug delivery systems include a cartridge configured to hold a liquid drug. A cartridge stopper is positioned in a first portion of the cartridge. A needle guide component is positioned within the cartridge stopper. A needle is positioned within a central opening of the needle guide. A plunger is positioned in a second portion of the cartridge. The plunger includes a fluid path pocket facing and aligned with the central opening of the needle guide component. The plunger is driven toward the cartridge stopper to expel the liquid drug from the cartridge through the needle. An end of the needle can be positioned within the fluid path pocket when the plunger is pushed against the cartridge stopper, ensuring that only a small volume of the liquid drug remains in the cartridge when delivery of the liquid drug is completed.
-
公开(公告)号:US20200164143A1
公开(公告)日:2020-05-28
申请号:US16697920
申请日:2019-11-27
Applicant: Insulet Corporation
Inventor: Steven CARDINALI , Lucas MCGAHREN , Nicholas LAU , Ian MCLAUGHLIN
Abstract: A multiple pulse volume shuttle pump powered by a shape memory alloy (SMA) wire is disclosed. In some embodiments, a shuttle pump system may include a pump chamber, a valve operable with the pump chamber, and a wire coupled to a valve shaft of the valve for controlling a position of the valve. The shuttle pump system may further include a pin disposed within an inset pathway of a cam, wherein the pin is moveable between multiple positions of the inset pathway in response to actuation of the valve shaft.
-
公开(公告)号:US20190038835A1
公开(公告)日:2019-02-07
申请号:US16049388
申请日:2018-07-30
Applicant: Insulet Corporation
Inventor: David NAZZARO , Ian MCLAUGHLIN , Daniel ALLIS , Jason O'CONNOR
Abstract: A fluid flow regulator of a fluid delivery system that can adjust a flow rate of a liquid drug dispensed from a liquid drug container to a user is provided. The fluid flow regulator can be coupled to an end of the liquid drug container. The fluid flow regulator can include a compliance plate and a flow channel selector plate having a fluid flow channel. The flow channel selector plate can be rotated relative to the compliance plate and the liquid drug container to expose a selected portion of the fluid flow channel to openings in the compliance plate that are in fluid communication with the liquid drug stored in the liquid drug container. The selected portion of the fluid flow channel can correspond to a corresponding flow resistance of the liquid drug through the fluid flow channel, thereby regulating the flow of the liquid drug to the user.
-
公开(公告)号:US20190038828A1
公开(公告)日:2019-02-07
申请号:US16053227
申请日:2018-08-02
Applicant: Insulet Corporation
Inventor: Ian MCLAUGHLIN
CPC classification number: A61M5/001 , A61L2/0094 , A61L2/206 , A61L2202/182 , A61L2202/21 , A61L2202/23 , A61L2202/24 , A61M5/002 , A61M5/14248 , A61M5/3129 , A61M2005/3114 , A61M2005/312 , A61M2005/3128 , A61M2005/3131 , A61M2209/045
Abstract: A system for sterilizing a drug delivery device includes a drug delivery device having a first self-healing seal configured to seal a fluid reservoir disposed within the drug delivery device. A sealable container is configured to receive the drug delivery device therein. The sealable container has a base portion and a cover portion. The cover portion has a second self-healing seal positioned to align with the first self-healing seal when the drug delivery device is disposed within the sealable container. A fill port includes a fill path, the fill path being configured to pass through the first and second self-healing seals to fluidly couple the fill port to the reservoir of the drug delivery device. Other systems, methods, and devices of sterilization are also disclosed.
-
公开(公告)号:US20180236173A1
公开(公告)日:2018-08-23
申请号:US15901082
申请日:2018-02-21
Applicant: Insulet Corporation
Inventor: Maureen MCCAFFREY , Ian MCLAUGHLIN
CPC classification number: A61M5/2466 , A61M5/14244 , A61M5/14248 , A61M5/14566 , A61M5/162 , A61M5/2033 , A61M5/288 , A61M5/3202 , A61M2005/14252 , A61M2005/1581 , A61M2005/1585 , A61M2005/208 , A61M2005/2474 , A61M2005/31518 , A61M2205/3386 , A61M2205/58 , A61M2205/82
Abstract: Systems for piercing a septum of a drug delivery device is disclosed. The drug delivery device may include a needle conduit having an end and a drug container having a septum. The septum piercing mechanism may include a needle support operatively coupled to the needle conduit. The septum piercing mechanism may be movable from a first, unactivated configuration to a second, activated configuration. In the unactivated configuration, the septum seals an interior of the drug container from the end of the needle conduit. In the activated configuration, the end of the needle conduit pierces through the septum placing the needle conduit in fluid communication with the drug container. In one embodiment, activation may cause the needle support to move towards the drug container. In one embodiment, the needle support may be moved by a biasing member. Alternatively, in another embodiment, the needle support may be moved by a cam mechanism.
-
公开(公告)号:US20240269379A1
公开(公告)日:2024-08-15
申请号:US18643990
申请日:2024-04-23
Applicant: INSULET CORPORATION
Inventor: Jason O'CONNOR , Ian MCLAUGHLIN , Daniel ALLIS , David NAZZARO
CPC classification number: A61M5/14566 , A61M5/14248 , A61M5/1582 , A61M5/162 , A61M5/16881 , A61M2005/14252 , A61M2205/3379 , A61M2205/583
Abstract: Disclosed are examples for a system for drug delivery and components thereof. The system may include an on-body pump device and a secondary unit. The on-body pump device may include a reservoir and a fluid pathway. The reservoir may be configured to hold a liquid drug. The secondary unit may be removably coupled to the on-body pump device. The secondary unit may be configured to receive a prefilled cartridge containing a liquid drug, expel the liquid drug from the prefilled cartridge, and deliver the liquid drug to the reservoir of the on-body pump device via the fluid pathway. Examples of variations to the secondary unit are also disclosed.
-
公开(公告)号:US20230414865A1
公开(公告)日:2023-12-28
申请号:US18340339
申请日:2023-06-23
Applicant: INSULET CORPORATION
Inventor: Jianhong ZHAO , Soroush KAMRAVA , James CAUSEY , Daniel BARRETT , Craig BRODEUR , Eric DUHAMEL , Ann LIU , Ian MCLAUGHLIN
CPC classification number: A61M5/14248 , A61M5/158 , A61M5/148 , A61M2005/14252 , A61M2005/1585
Abstract: A drug delivery device including a reservoir operable to contain a liquid drug, a fluid outlet including an outlet reservoir opening and an outlet fluid channel, wherein the outlet reservoir opening has a volume and is fluidly coupled to the outlet fluid channel, and an outlet filter plug operable to fill the volume of the outlet reservoir opening and collect particulate material as the liquid drug is expelled from the reservoir.
-
公开(公告)号:US20220105267A1
公开(公告)日:2022-04-07
申请号:US17492103
申请日:2021-10-01
Applicant: Insulet Corporation
Inventor: Steven CARDINALI , David NAZZARO , Ian MCLAUGHLIN
Abstract: Methods and apparatuses for performing an insertion process for a plurality of penetrating elements are described. For example, a wearable fluid infusion device may include a cannula and/or needle for infusing a fluid into a patient and a sensor for sensing a physical characteristic of the patient. A non-limiting example of a fluid may be or may include insulin. An illustrative and non-restrictive example of a physical characteristic may include a blood glucose level. The wearable infusion device may be configured to facilitate insertion of the multiple penetrating elements, such as a cannula and a sensor, in a single simultaneous insertion step instead of requiring individual insertion steps for each of multiple penetrating elements. Other embodiments are described.
-
公开(公告)号:US20220062550A1
公开(公告)日:2022-03-03
申请号:US17412684
申请日:2021-08-26
Applicant: Insulet Corporation
Inventor: David NAZZARO , Jason O'CONNOR , Ian MCLAUGHLIN , Joon Bok LEE , Thomas METZMAKER , Bret CHRISTENSEN , Philip HILLDALE
Abstract: Embodiments of the present disclosure relate to approaches for transitioning a drug delivery device from a low-energy sleep state to a high-energy active state. In some embodiments, a system may include a drug delivery device, the drug delivery device including a pump mechanism coupled to a reservoir for expelling a liquid drug from the reservoir; and an activation component communicatively coupled to the pump mechanism. The activation component may include at least one of a sensor and a mechanical activation device, and a wake-up circuit operable to receive an input from the sensor or the mechanical activation device, wherein the input indicates a change in a device characteristic. Based on the change in the device characteristic, the wake-up circuit may be further operable to transition the drug delivery device from a low-energy state to an active state.
-
公开(公告)号:US20210379293A1
公开(公告)日:2021-12-09
申请号:US17408523
申请日:2021-08-23
Applicant: Insulet Corporation
Inventor: David NAZZARO , Ian MCLAUGHLIN , Simon KOZIN , Maureen MCCAFFREY , Jackie MAC , Alexander DOUDOUMOPOULOS , Bhavin PATEL
Abstract: A wearable drug delivery device that can deliver a liquid drug stored in a container to a patient is provided. The container can be a prefilled cartridge that can be loaded into the drug delivery device by the patient or that can be preloaded within the drug delivery device when provided to the patient. A sealed end of the container is pierced to couple the stored liquid drug to a needle conduit that is coupled to a needle insertion component that provides access to the patient. A drive system of the drug delivery device can expel the liquid drug from the cartridge to the patient through the needle conduit. The drive system can be controlled to provide the liquid drug to the patient in a single dose or over multiple doses.
-
-
-
-
-
-
-
-
-